Depressive disorders are characterized by sadness severe enough or persistent enough to interfere with function and often by decreased interest or pleasure in activities. Exact cause is unknown but probably involves heredity, changes in neurotransmitter levels, altered neuroendocrine function, and psychosocial factors. Diagnosis is based on history. Treatment usually consists of drugs, psychotherapy, or both and sometimes electroconvulsive therapy or rapid transcranial magnetic stimulation (rTMS).
The term depression is often used to refer to any of several depressive disorders. Some are classified in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) by specific symptoms:
- Major depressive disorder (often called major depression)
- Persistent depressive disorder (dysthymia)
- Other specified or unspecified depressive disorder
Others are classified by etiology:
- Premenstrual dysphoric disorder
- Depressive disorder due to another medical condition
- Substance/medication-induced depressive disorder
Depressive disorders occur at any age but typically develop during the mid teens, 20s, or 30s (see also Depressive Disorders in Children and Adolescents). In primary care settings, as many as 30% of patients report depressive symptoms, but < 10% have major depression.
Depressive disorders are characterized by sadness severe enough or persistent enough to interfere with function and often by decreased interest or pleasure in activities. Exact cause is unknown but probably involves heredity, changes in neurotransmitter levels, altered neuroendocrine function, and psychosocial factors. Diagnosis is based on history. Treatment usually consists of drugs, psychotherapy, or both and sometimes electroconvulsive therapy or rapid transcranial magnetic stimulation (rTMS).
The term depression is often used to refer to any of several depressive disorders. Some are classified in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) by specific symptoms:
- Major depressive disorder (often called major depression)
- Persistent depressive disorder (dysthymia)
- Other specified or unspecified depressive disorder
Others are classified by etiology:
- Premenstrual dysphoric disorder
- Depressive disorder due to another medical condition
- Substance/medication-induced depressive disorder
Depressive disorders occur at any age but typically develop during the mid teens, 20s, or 30s (see also Depressive Disorders in Children and Adolescents). In primary care settings, as many as 30% of patients report depressive symptoms, but < 10% have major depression.
Some Causes of Symptoms of Depression and Mania*
Type of Disorder | Depression | Mania |
Connective tissue | SLE | |
Endocrine | Hyperthyroidism | |
Infectious | General paresis (parenchymatous neurosyphilis) Viral pneumonia | AIDS General paresis Influenza St. Louis encephalitis |
Neoplastic | Cancer of the head of the pancreas Disseminated carcinomatosis | — |
Neurologic | Complex partial seizures (temporal lobe) Stroke (left frontal) | Complex partial seizures (temporal lobe) Diencephalic tumors Head trauma Multiple sclerosis Stroke |
Nutritional | — | |
Other | — | |
Pharmacologic | Amphotericin B Anticholinesterase insecticides Beta-blockers (some, eg, propranolol) Cimetidine Corticosteroids Cycloserine Estrogen therapy Indomethacin Interferon Mercury Methyldopa Metoclopramide Phenothiazines Reserpine Thallium Vinblastine Vincristine | Certain antidepressants Bromocriptine Corticosteroids Levodopa Methylphenidate Sympathomimetic drugs |
Mental (other than mood disorders) | Alcohol and other substance use disorders Antisocial personality disorder Borderline personality disorder Dementing disorders in the early phase | — |
* Depression commonly occurs in these disorders, but no causal relationship has been established. | ||
Symptoms and Signs
Depression causes cognitive, psychomotor, and other types of dysfunction (eg, poor concentration, fatigue, loss of sexual desire, loss of interest or pleasure in nearly all activities that were previously enjoyed, sleep disturbances), as well as a depressed mood. People with a depressive disorder frequently have thoughts of suicide and may attempt suicide. Other mental symptoms or disorders (eg, anxiety and panic attacks) commonly coexist, sometimes complicating diagnosis and treatment.
Patients with all forms of depression are more likely to abuse alcohol or other recreational drugs in an attempt to self-treat sleep disturbances or anxiety symptoms; however, depression is a less common cause of alcoholic use disorder and other substance use disorders than was once thought. Patients are also more likely to become heavy smokers and to neglect their health, increasing the risk of development or progression of other disorders (eg, chronic obstructive pulmonary disease [COPD]).
Depression may reduce protective immune responses. Depression increases risk of cardiovascular disorders, myocardial infarctions (MIs), and stroke, perhaps because in depression, cytokines and factors that increase blood clotting are elevated and heart rate variability is decreased—all potential risk factors for cardiovascular disorders.
Major depression (unipolar disorder)
Patients may appear miserable, with tearful eyes, furrowed brows, down-turned corners of the mouth, slumped posture, poor eye contact, lack of facial expression, little body movement, and speech changes (eg, soft voice, lack of prosody, use of monosyllabic words). Appearance may be confused with Parkinson disease. In some patients, depressed mood is so deep that tears dry up; they report that they are unable to experience usual emotions and feel that the world has become colorless and lifeless.
Nutrition may be severely impaired, requiring immediate intervention.
Some depressed patients neglect personal hygiene or even their children, other loved ones, or pets.
For diagnosis of major depression, ≥ 5 of the following must have been present nearly every day during the same 2-week period, and one of them must be depressed mood or loss of interest or pleasure:
- Depressed mood most of the day
- Markedly diminished interest or pleasure in all or almost all activities for most of the day
- Significant (> 5%) weight gain or loss or decreased or increased appetite
- Insomnia (often sleep-maintenance insomnia) or hypersomnia
- Psychomotor agitation or retardation observed by others (not self-reported)
- Fatigue or loss of energy
- Feelings of worthlessness or excessive or inappropriate guilt
- Diminished ability to think or concentrate or indecisiveness
- Recurrent thoughts of death or suicide, a suicide attempt, or a specific plan for committing suicide
Persistent depressive disorder
Depressive symptoms that persist for ≥ 2 years without remission are classified as persistent depressive disorder (PDD), a category that consolidates disorders formerly termed chronic major depressive disorder and dysthymic disorder.
Symptoms typically begin insidiously during adolescence and may persist for many years or decades. The number of symptoms often fluctuates above and below the threshold for major depressive episode.
Affected patients may be habitually gloomy, pessimistic, humorless, passive, lethargic, introverted, hypercritical of self and others, and complaining. Patients with PDD are also more likely to have underlying anxiety disorders, substance use disorders, or personality (ie, borderline personality) disorders.
For diagnosis of persistent depressive disorder, patients must have had a depressed mood for most of the day for more days than not for ≥ 2 years plus ≥ 2 of the following:
- Poor appetite or overeating
- Insomnia or hypersomnia
- Low energy or fatigue
- Low self-esteem
- Poor concentration or difficulty making decisions
- Feelings of hopelessness
Premenstrual dysphoric disorder
Premenstrual dysphoric disorder involves mood and anxiety symptoms that are clearly related to the menstrual cycle, with onset during the premenstrual phase and a symptom-free interval after menstruation. Symptoms must be present during most menstrual cycles during the past year.
Manifestations are similar to those of premenstrual syndrome but are more severe, causing clinically significant distress and/or marked impairment of social or occupational functioning. The disorder may begin any time after menarche; it may worsen as menopause approaches but ceases after menopause. Prevalence is estimated at 2 to 6% of menstruating women in a given 12-month interval.
For diagnosis of premenstrual dysphoric disorder, patients must have ≥ 5 symptoms during the week before menstruation. Symptoms must begin to remit within a few days after onset of menses and become minimal or absent in the week after menstruation. Symptoms must include ≥ 1 of the following:
- Marked mood swings (eg, suddenly feeling sad or tearful)
- Marked irritability or anger or increased interpersonal conflicts
- Marked depressed mood, feelings of hopelessness, or self-deprecating thoughts
- Marked anxiety, tension, or an on-edge feeling
In addition, ≥ 1 of the following must be present:
- Decreased interest in usual activities
- Difficulty concentrating
- Low energy or fatigue
- Marked change in appetite, overeating, or specific food cravings
- Hypersomnia or insomnia
- Feeling overwhelmed or out of control
- Physical symptoms such as breast tenderness or swelling, joint or muscle pain, a feeling of being bloated, and weight gain
Other depressive disorder
Clusters of symptoms with characteristics of a depressive disorder that do not meet the full criteria for other depressive disorders but that cause clinically significant distress or impairment of functioning are classified as other depressive (specified or unspecified) disorder.
Included are recurrent periods of dysphoria with ≥ 4 other depressive symptoms that last < 2 weeks in people who have never met criteria for another mood disorder (eg, recurrent brief depression) and depressive periods that last longer but that include insufficient symptoms for diagnosis of another depressive disorder.
Specifiers
Major depression and persistent depressive disorder may include one or more specifiers that describe additional manifestations during a depressive episode:
- Anxious distress: Patients feel tense and unusually restless; they have difficulty concentrating because they worry or fear that something awful may happen, or they feel that they may lose control of themselves.
- Mixed features: Patients also have ≥ 3 manic or hypomanic symptoms (eg, elevated mood, grandiosity, greater talkativeness than usual, flight of ideas, decreased sleep). Patients who have this type of depression are at risk of developing bipolar disorder.
- Melancholic: Patients have lost pleasure in nearly all activities or do not respond to usually pleasurable stimuli. They may be despondent and despairing, feel excessive or inappropriate guilt, or have early morning awakenings, marked psychomotor retardation or agitation, and significant anorexia or weight loss.
- Atypical: Patients’ mood temporarily brightens in response to positive events (eg, a visit from children). They also have ≥ 2 of the following: overreaction to perceived criticism or rejection, feelings of leaden paralysis (a heavy or weighted-down feeling, usually in the extremities), weight gain or increased appetite, and hypersomnia.
- Psychotic: Patients have delusions and/or hallucinations. Delusions often involve having committed unpardonable sins or crimes, harboring incurable or shameful disorders, or being persecuted. Hallucinations may be auditory (eg, hearing accusatory or condemning voices) or visual. If only voices are described, careful consideration should be given to whether the voices represent true hallucinations.
- Catatonic: Patients have severe psychomotor retardation, engage in excessive purposeless activity, and/or withdraw; some patients grimace and mimic speech (echolalia) or movement (echopraxia).
- Peripartum onset: Onset is during pregnancy or in the 4 weeks after delivery. Psychotic features may be present; infanticide is often associated with psychotic episodes involving command hallucinations to kill the infant or delusions that the infant is possessed.
- Seasonal pattern: Episodes occur at a particular time of year, most often fall or winter.
Diagnosis
- Clinical criteria (DSM-5)
- Complete blood count (CBC), electrolytes, and thyroid-stimulating hormone (TSH), vitamin B12, and folate levels to rule out physical disorders that can cause depression
Diagnosis of depressive disorders is based on identification of the symptoms and signs and the clinical criteria described above. To help differentiate depressive disorders from ordinary mood variations, there must be significant distress or impairment in social, occupational, or other important areas of functioning.
Several brief questionnaires are available for screening. They help elicit some depressive symptoms but cannot be used alone for diagnosis. Specific close-ended questions help determine whether patients have the symptoms required by DSM-5 criteria for diagnosis of major depression.
Severity is determined by the degree of pain and disability (physical, social, occupational) and by duration of symptoms. A physician should gently but directly ask patients about any thoughts and plans to harm themselves or others, any previous threats of and/or attempts at suicide, and other risk factors. Psychosis and catatonia indicate severe depression. Melancholic features indicate severe or moderate depression. Coexisting physical conditions, substance use disorders, and anxiety disorders may add to severity.
Differential diagnosis
Depressive disorders must be distinguished from demoralization and grief. Other mental disorders (eg, anxiety disorders) can mimic or obscure the diagnosis of depression. Sometimes more than one disorder is present. Major depression (unipolar disorder) must be distinguished from bipolar disorder.
In older patients, depression can manifest as dementia of depression (formerly called pseudodementia), which causes many of the symptoms and signs of dementia such as psychomotor retardation and decreased concentration. However, early dementia may cause depression. In general, when the diagnosis is uncertain, treatment of a depressive disorder should be tried.
Differentiating chronic depressive disorders, such as dysthymia, from substance use disorders may be difficult, particularly because they can coexist and may contribute to each other.
Physical disorders must also be excluded as a cause of depressive symptoms. Hypothyroidism often causes symptoms of depression and is common, particularly among older patients. Parkinson disease, in particular, may manifest with symptoms that mimic depression (eg, loss of energy, lack of expression, paucity of movement). A thorough neurologic examination is needed to exclude this disorder.
Testing
No laboratory findings are pathognomonic for depressive disorders. However, laboratory testing is necessary to exclude physical conditions that can cause depression. Tests include complete blood count, thyroid-stimulating hormone levels, and routine electrolyte, vitamin B12, and folate levels and, in older men, testosterone levels. Testing for illicit drug use is sometimes appropriate.
Treatment
- Support
- Psychotherapy
- Drugs
(See also Drug Treatment of Depression.)
Symptoms may remit spontaneously, particularly when they are mild or of short duration. Mild depression may be treated with general support and psychotherapy. Moderate to severe depression is treated with drugs, psychotherapy, or both and sometimes electroconvulsive therapy. Some patients require a combination of drugs. Improvement may not be apparent until after 1 to 4 weeks of drug treatment.
Depression, especially in patients who have had > 1 episode, is likely to recur; therefore, severe cases often warrant long-term maintenance drug therapy.
Most people with depression are treated as outpatients. Patients with significant suicidal ideation, particularly when family support is lacking, require hospitalization, as do those with psychotic symptoms or physical debilitation.
In patients with substance use disorders, depressive symptoms often resolve within a few months of stopping substance use. Antidepressant treatment is much less likely to be effective while substance use continues.
If a physical disorder or drug toxicity could be the cause, treatment is directed first at the underlying disorder. However, if the diagnosis is in doubt or if symptoms are disabling or include suicidal ideation or hopelessness, a therapeutic trial with an antidepressant or a mood-stabilizing drug may help.
Initial support
Until definite improvement begins, a physician may need to see patients weekly or biweekly to provide support and education and to monitor progress. Telephone calls may supplement office visits.
Patients and loved ones may be worried or embarrassed about the idea of having a mental disorder. The physician can help by explaining that depression is a serious medical disorder caused by biologic disturbances and requires specific treatment and that the prognosis with treatment is good. Patients and loved ones should be reassured that depression does not reflect a character flaw (eg, laziness, weakness). Telling patients that the path to recovery often fluctuates helps them put feelings of hopelessness in perspective and improves adherence.
Encouraging patients to gradually increase simple activities (eg, taking walks, exercising regularly) and social interactions must be balanced with acknowledging their desire to avoid activities. The physician can suggest that patients avoid self-blame and explain that dark thoughts are part of the disorder and will go away.
Psychotherapy
Numerous controlled trials have shown that psychotherapy, particularly cognitive-behavioral therapy and interpersonal therapy, is effective in patients with major depressive disorder, both to treat acute symptoms and to decrease the likelihood of relapse. Patients with mild depression tend to have better outcomes than those with more severe depression, but the magnitude of improvement is greater in those with more severe depression.
Drug therapy for depression
Several drug classes and drugs can be used to treat depression:
- Selective serotonin reuptake inhibitors (SSRIs)
- Serotonin modulators (5-HT2 blockers)
- Serotonin-norepinephrine reuptake inhibitors
- Norepinephrine-dopamine reuptake inhibitor
- Heterocyclic antidepressants
- Monoamine oxidase inhibitors (MAOIs)
- Melatonergic antidepressant
- Ketamine-like drugs
Choice of drug may be guided by past response to a specific antidepressant. Otherwise, SSRIs are often the initial drugs of choice. Although the different SSRIs are equally effective for typical cases, certain properties of the drugs make them more or less appropriate for certain patients (see table Antidepressants).
Treatment references
- McIntyre RS, Lee y, Zhou AJ et al: The efficacy of psychostimulants in major depressive episodes: A systematic review and meta-analysis. J Clin Pscyhopharmacol 37 (4):412-418, 2017. doi: 10.1097/JCP.0000000000000723.
- Bergfeld IO, Mantione M, Hoogendoorn MLC, et al: Deep brain stimulation of the ventral anterior limb of the internal capsule for treatment-resistant depression: A randomized clinical trial. JAMA Psychiatry 73 (5):456–64, 2016. doi: 10.1001/jamapsychiatry.2016.0152.


